Excessive Cell Growth Causes Cytoplasm Dilution And Contributes to Senescence.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
21 02 2019
Historique:
received: 27 02 2018
revised: 15 11 2018
accepted: 09 01 2019
pubmed: 12 2 2019
medline: 7 1 2020
entrez: 12 2 2019
Statut: ppublish

Résumé

Cell size varies greatly between cell types, yet within a specific cell type and growth condition, cell size is narrowly distributed. Why maintenance of a cell-type specific cell size is important remains poorly understood. Here we show that growing budding yeast and primary mammalian cells beyond a certain size impairs gene induction, cell-cycle progression, and cell signaling. These defects are due to the inability of large cells to scale nucleic acid and protein biosynthesis in accordance with cell volume increase, which effectively leads to cytoplasm dilution. We further show that loss of scaling beyond a certain critical size is due to DNA becoming limiting. Based on the observation that senescent cells are large and exhibit many of the phenotypes of large cells, we propose that the range of DNA:cytoplasm ratio that supports optimal cell function is limited and that ratios outside these bounds contribute to aging.

Identifiants

pubmed: 30739799
pii: S0092-8674(19)30051-0
doi: 10.1016/j.cell.2019.01.018
pmc: PMC6386581
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1083-1097.e18

Subventions

Organisme : Wellcome Trust
ID : FC001203
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : R01 HD085866
Pays : United States
Organisme : Wellcome Trust
ID : 110275/Z/15/Z
Pays : United Kingdom
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA240765
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK098285
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG011085
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : U54 CA217377
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM132447
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007287
Pays : United States
Organisme : Medical Research Council
ID : FC001203
Pays : United Kingdom
Organisme : Cancer Research UK
ID : FC001203
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : R01 GM046498
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Annu Rev Cell Dev Biol. 2012;28:113-35
pubmed: 22804576
Genes Dev. 2018 Aug 1;32(15-16):1075-1084
pubmed: 30042134
Dev Cell. 2016 Feb 8;36(3):344-52
pubmed: 26859356
Cytogenet Genome Res. 2005;110(1-4):70-90
pubmed: 16093660
Yeast. 1998 Jul;14(10):953-61
pubmed: 9717241
Nat Commun. 2018 Oct 29;9(1):4496
pubmed: 30374016
Cell. 2018 Jul 12;174(2):338-349.e20
pubmed: 29937223
Nat Cell Biol. 2001 Jan;3(1):E23-7
pubmed: 11146646
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nature. 2013 Feb 28;494(7438):480-3
pubmed: 23446419
Cell. 2013 Sep 12;154(6):1194-205
pubmed: 24034244
Cell. 1996 Feb 23;84(4):633-42
pubmed: 8598049
Curr Biol. 2009 Sep 29;19(18):1549-54
pubmed: 19682904
Science. 2015 May 15;348(6236):1245075
pubmed: 25977557
Curr Biol. 2010 Nov 23;20(22):2010-5
pubmed: 20970341
J Cell Biol. 2017 Feb;216(2):317-330
pubmed: 28043970
Mol Cell. 2015 Apr 16;58(2):339-52
pubmed: 25866248
FEMS Yeast Res. 2007 May;7(3):422-35
pubmed: 17233766
Genes Dev. 2014 Feb 15;28(4):396-408
pubmed: 24532716
BMC Bioinformatics. 2013 Dec 03;14:349
pubmed: 24299066
J Proteomics. 2016 Oct 4;148:85-93
pubmed: 27432472
Cell Cycle. 2008 Nov 1;7(21):3355-61
pubmed: 18948731
Science. 2011 Apr 22;332(6028):465-8
pubmed: 21393511
Exp Cell Res. 1977 Mar 1;105(1):79-98
pubmed: 320023
Yeast. 2004 Aug;21(11):947-62
pubmed: 15334558
Nat Biotechnol. 2016 Oct;34(10):1052-1059
pubmed: 27598230
Biogerontology. 2009 Aug;10(4):481-8
pubmed: 18985429
Anal Chem. 2014 Jul 15;86(14):7150-8
pubmed: 24927332
Nature. 1959 Jun 20;183(4677):1751-2
pubmed: 13666896
Cell. 2012 Sep 14;150(6):1170-81
pubmed: 22959267
Anal Chem. 2012 Sep 4;84(17):7469-78
pubmed: 22880955
J Cell Biol. 2015 Nov 23;211(4):757-63
pubmed: 26598613
Curr Biol. 2013 Jul 22;23(14):1269-79
pubmed: 23810534
Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):999-1004
pubmed: 20080562
Yeast. 2000 Oct;16(14):1313-23
pubmed: 11015728
Cell. 2010 Dec 23;143(7):1174-89
pubmed: 21183079
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4916-20
pubmed: 22421136
Genetics. 2005 Apr;169(4):1915-25
pubmed: 15716499
Cell Cycle. 2011 Jan 1;10(1):144-55
pubmed: 21248481
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Mol Biol Cell. 2000 Dec;11(12):4241-57
pubmed: 11102521
Cell. 2004 Jun 25;117(7):899-913
pubmed: 15210111
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14315-22
pubmed: 15353587
Genes Dev. 2004 Oct 15;18(20):2491-505
pubmed: 15466158
Dev Cell. 2016 Nov 7;39(3):370-382
pubmed: 27720611
J Bacteriol. 1984 May;158(2):701-4
pubmed: 6373726
Cell. 2012 Oct 26;151(3):671-83
pubmed: 23101633
Genes Dev. 1992 Apr;6(4):557-67
pubmed: 1313770
J Bacteriol. 1970 Dec;104(3):1280-5
pubmed: 16559104
Curr Biol. 2012 May 8;22(9):R350-9
pubmed: 22575477
Genes Dev. 2009 Jun 15;23(12):1408-22
pubmed: 19528319
Exp Cell Res. 1961 Dec;25:585-621
pubmed: 13905658
Aging Cell. 2017 Aug;16(4):661-671
pubmed: 28455874
Annu Rev Biophys. 2008;37:375-97
pubmed: 18573087

Auteurs

Gabriel E Neurohr (GE)

David H. Koch Institute for Integrative Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Rachel L Terry (RL)

David H. Koch Institute for Integrative Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Jette Lengefeld (J)

David H. Koch Institute for Integrative Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Megan Bonney (M)

David H. Koch Institute for Integrative Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Novartis Institute for Biomedical Research, Oncology Department, Cambridge, MA 02139.

Gregory P Brittingham (GP)

Institute for Systems Genetics, New York University Langone Health, New York, NY 10016, USA.

Fabien Moretto (F)

Cell Fate and Gene Regulation Laboratory, The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK.

Teemu P Miettinen (TP)

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; MRC Laboratory for Molecular Cell Biology, University College London, Gower Street, London, WC1E 6BT, UK.

Laura Pontano Vaites (LP)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

Luis M Soares (LM)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Joao A Paulo (JA)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

J Wade Harper (JW)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

Stephen Buratowski (S)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Scott Manalis (S)

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Folkert J van Werven (FJ)

Cell Fate and Gene Regulation Laboratory, The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK.

Liam J Holt (LJ)

Institute for Systems Genetics, New York University Langone Health, New York, NY 10016, USA.

Angelika Amon (A)

David H. Koch Institute for Integrative Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: angelika@mit.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH